NASDAQ: CRDL
Cardiol Therapeutics Inc Stock Ownership - Who owns Cardiol Therapeutics?

Insider buying vs selling

Have Cardiol Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CRDL insiders and whales buy or sell their stock.

CRDL Shareholders

What type of owners hold Cardiol Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mmcspc0.01%15,599$29.25kInstitution
Mmcap International Inc Spc0.01%15,598$29.25kInstitution
Tejara0.00%5,114$9.59kInstitution
Tejara Capital Ltd0.00%5,113$9.59kInstitution
Ikaria0.00%3,325$6.23kInstitution
Ikarian Capital LLC0.00%3,325$6.23kInstitution
Boothb0.00%976$1.83kInstitution
Boothbay Fund Management LLC0.00%975$1.83kInstitution
Citade0.00%797$1.49kInstitution
Citadel Advisors LLC0.00%796$1.49kInstitution

1 of 3

CRDL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRDL0.03%0.00%
SIGA0.05%86.77%Net Selling
DERM0.04%31.07%
ACB0.01%0.00%
ORGO0.01%99.99%Net Selling

Cardiol Therapeutics Stock Ownership FAQ

Who owns Cardiol Therapeutics?

Cardiol Therapeutics (NASDAQ: CRDL) is owned by 0.03% institutional shareholders, 0.00% Cardiol Therapeutics insiders, and 99.97% retail investors. Mmcspc is the largest individual Cardiol Therapeutics shareholder, owning 15,599.00 shares representing 0.01% of the company. Mmcspc's Cardiol Therapeutics shares are currently valued at $29.25k.

If you're new to stock investing, here's how to buy Cardiol Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.